430 related articles for article (PubMed ID: 17397875)
61. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats.
Liu R; Ahmed KM; Nantajit D; Rosenthal FS; Hai CX; Li JJ
Int J Mol Med; 2007 Jun; 19(6):865-73. PubMed ID: 17487418
[TBL] [Abstract][Full Text] [Related]
62. Protection from pulmonary fibrosis in leukotriene-deficient mice.
Peters-Golden M; Bailie M; Marshall T; Wilke C; Phan SH; Toews GB; Moore BB
Am J Respir Crit Care Med; 2002 Jan; 165(2):229-35. PubMed ID: 11790660
[TBL] [Abstract][Full Text] [Related]
63. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Oct; 291(1):367-73. PubMed ID: 10490926
[TBL] [Abstract][Full Text] [Related]
64. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
[TBL] [Abstract][Full Text] [Related]
65. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
[TBL] [Abstract][Full Text] [Related]
66. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
[TBL] [Abstract][Full Text] [Related]
67. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.
Xu PB; Mao YF; Meng HB; Tian YP; Deng XM
Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985
[TBL] [Abstract][Full Text] [Related]
68. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
69. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
70. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.
Failla M; Genovese T; Mazzon E; Gili E; Muià C; Sortino M; Crimi N; Caputi AP; Cuzzocrea S; Vancheri C
Respir Res; 2006 Nov; 7(1):137. PubMed ID: 17118201
[TBL] [Abstract][Full Text] [Related]
71. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro.
Liu J; Wang X; Wang F; Teng L; Cao J
Biomed Pharmacother; 2009 Aug; 63(7):484-91. PubMed ID: 18602243
[TBL] [Abstract][Full Text] [Related]
72. Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Shimaoka Y; Tajima S; Fujimori F; Yamabayashi C; Moriyama H; Terada M; Takada T; Suzuki E; Bando M; Sugiyama Y; Narita I
Lung; 2009; 187(5):331-9. PubMed ID: 19672658
[TBL] [Abstract][Full Text] [Related]
73. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Erden ES; Kirkil G; Deveci F; Ilhan N; Cobanoğlu B; Turgut T; Muz MH
Tuberk Toraks; 2008; 56(2):127-38. PubMed ID: 18701972
[TBL] [Abstract][Full Text] [Related]
74. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
75. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.
Lee SH; Lee EJ; Lee SY; Kim JH; Shim JJ; Shin C; In KH; Kang KH; Uhm CS; Kim HK; Yang KS; Park S; Kim HS; Kim YM; Yoo TJ
Exp Lung Res; 2014 Apr; 40(3):117-25. PubMed ID: 24624895
[TBL] [Abstract][Full Text] [Related]
76. In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis.
Yoshida M; Sakuma-Mochizuki J; Abe K; Arai T; Mori M; Goya S; Matsuoka H; Hayashi S; Kaneda Y; Kishimoto T
Biochem Biophys Res Commun; 1999 Nov; 265(2):503-8. PubMed ID: 10558898
[TBL] [Abstract][Full Text] [Related]
77. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
78. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
Long X; Xiong SD; Xiong WN; Xu YJ
Chin Med J (Engl); 2007 Aug; 120(16):1432-7. PubMed ID: 17825173
[TBL] [Abstract][Full Text] [Related]
79. [A preliminary study of CTGF in bleomycin-induced mouse pulmonary fibrosis].
Zhang L; Lu HP; Lai GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):290-2. PubMed ID: 15862142
[TBL] [Abstract][Full Text] [Related]
80. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
